60 related articles for article (PubMed ID: 10434155)
1. [Specifics of a dual action: toward new and more effective antidepressants?].
Martin P
Encephale; 1999 Jun; 25 Spec No 2():5-20; discussion 23-5. PubMed ID: 10434155
[TBL] [Abstract][Full Text] [Related]
2. New approaches to the treatment of depression.
Leonard BE
J Clin Psychiatry; 1996; 57 Suppl 4():26-33. PubMed ID: 8636063
[TBL] [Abstract][Full Text] [Related]
3. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Bacq A; Balasse L; Biala G; Guiard B; Gardier AM; Schinkel A; Louis F; Vialou V; Martres MP; Chevarin C; Hamon M; Giros B; Gautron S
Mol Psychiatry; 2012 Sep; 17(9):926-39. PubMed ID: 21769100
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
5. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
[TBL] [Abstract][Full Text] [Related]
6. History and evolution of the monoamine hypothesis of depression.
Hirschfeld RM
J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
[TBL] [Abstract][Full Text] [Related]
7. Can monoamine-based therapies be improved?
Demitrack MA
J Clin Psychiatry; 2002; 63 Suppl 2():14-8. PubMed ID: 15453009
[TBL] [Abstract][Full Text] [Related]
8. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
Jaracz J; Rybakowski J
Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
[TBL] [Abstract][Full Text] [Related]
9. Invivo antioxidant status: a putative target of antidepressant action.
Zafir A; Ara A; Banu N
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
11. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
12. Depression: the case for a monoamine deficiency.
Delgado PL
J Clin Psychiatry; 2000; 61 Suppl 6():7-11. PubMed ID: 10775018
[TBL] [Abstract][Full Text] [Related]
13. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
Trivedi MH; Hollander E; Nutt D; Blier P
J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic action lag time and resistance to treatment].
Peretti CS
Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
[TBL] [Abstract][Full Text] [Related]
15. The treatment of depression with different formulations of venlafaxine: a comparative analysis.
Olver JS; Burrows GD; Norman TR
Hum Psychopharmacol; 2004 Jan; 19(1):9-16. PubMed ID: 14716706
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
Baldomero EB; Ubago JG; Cercós CL; Ruiloba JV; Calvo CG; López RP
Depress Anxiety; 2005; 22(2):68-76. PubMed ID: 16094658
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter hypotheses of depression. Research update.
Jimerson DC
Psychiatr Clin North Am; 1984 Sep; 7(3):563-73. PubMed ID: 6207513
[TBL] [Abstract][Full Text] [Related]
18. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.
Kálmán J; Palotás A; Juhász A; Rimanóczy A; Hugyecz M; Kovács Z; Galsi G; Szabó Z; Pákáski M; Fehér LZ; Janka Z; Puskás LG
Neurochem Res; 2005 Nov; 30(11):1429-38. PubMed ID: 16341940
[TBL] [Abstract][Full Text] [Related]
19. [Current hypotheses on the mechanism of action of lithium. I. Lithium and neuromediators].
Wolf MA
Encephale; 1987; 13(1):3-11. PubMed ID: 2438125
[TBL] [Abstract][Full Text] [Related]
20. Functional brain circuits in major depression and remission.
Sackeim HA
Arch Gen Psychiatry; 2001 Jul; 58(7):649-50. PubMed ID: 11448370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
